Skip to main content

Peer Review reports

From: A comparison of misoprostol with and without methylergometrine and oxytocin in outpatient medical abortion: a phase III randomized controlled trial

Original Submission
2 Dec 2022 Submitted Original manuscript
17 Jan 2023 Author responded Author comments - Vahid Rahmanian
Resubmission - Version 2
17 Jan 2023 Submitted Manuscript version 2
25 Jan 2023 Author responded Author comments - Vahid Rahmanian
Resubmission - Version 3
25 Jan 2023 Submitted Manuscript version 3
28 Jan 2023 Author responded Author comments - Vahid Rahmanian
Resubmission - Version 4
28 Jan 2023 Submitted Manuscript version 4
6 Feb 2023 Author responded Author comments - Vahid Rahmanian
Resubmission - Version 5
6 Feb 2023 Submitted Manuscript version 5
7 Feb 2023 Author responded Author comments - Vahid Rahmanian
Resubmission - Version 6
7 Feb 2023 Submitted Manuscript version 6
12 Apr 2023 Reviewed Reviewer Report
24 Apr 2023 Reviewed Reviewer Report
10 May 2023 Author responded Author comments - Vahid Rahmanian
Resubmission - Version 7
10 May 2023 Submitted Manuscript version 7
18 May 2023 Author responded Author comments - Vahid Rahmanian
Resubmission - Version 8
18 May 2023 Submitted Manuscript version 8
20 May 2023 Author responded Author comments - Vahid Rahmanian
Resubmission - Version 9
20 May 2023 Submitted Manuscript version 9
7 Sep 2023 Author responded Author comments - Vahid Rahmanian
Resubmission - Version 10
7 Sep 2023 Submitted Manuscript version 10
Publishing
15 Sep 2023 Editorially accepted
5 Oct 2023 Article published 10.1186/s13104-023-06509-6

You can find further information about peer review here.

Back to article page